Pharma penny stock under Rs 35 in green after acquiring 10,000 shares of its Singapore subsidiary Pharma penny stock under Rs 35 in green after acquiring 10,000 shares of its Singapore subsidiary The stock gave multibagger returns of 467 per cent from its 52-week low of Rs 5.82 per share. Kiran Shroff / Thursday, February 27, 2025 0 129 Article rating: 5.0 The stock gave multibagger returns of 467 per cent from its 52-week low of Rs 5.82 per share. Read more
Pharma penny stock under Rs 60 in green after bagging new order worth USD 23,000 from FIRSTVET Veterinary Medicines Trading LLC Pharma penny stock under Rs 60 in green after bagging new order worth USD 23,000 from FIRSTVET Veterinary Medicines Trading LLC The stock is up 40.14 per cent from its 52-week low of Rs 41.10 per share. Kiran Shroff / Thursday, December 26, 2024 0 308 Article rating: 3.9 The shares of the company have an ROE of 25 per cent and an ROCE of 32 per cent. Read more
Pharma Penny Stock Under Rs 60 In Green After Bagging A Significant New Order Worth Rs 6,28,15,000 Pharma Penny Stock Under Rs 60 In Green After Bagging A Significant New Order Worth Rs 6,28,15,000 The company has a market cap of Rs 63 crore and on Tuesday, the stock was trading at Rs 53.80 per share on NSE. Kiran Shroff / Tuesday, November 19, 2024 0 288 Article rating: 4.0 The company has a market cap of Rs 63 crore and on Tuesday, the stock was trading at Rs 53.80 per share on NSE. Read more
Pharma penny stock under Rs 55 in green as company bags new order worth USD 19,200 from Genet International & FIRSTVET Veterinary Medicines Trading LLC Pharma penny stock under Rs 55 in green as company bags new order worth USD 19,200 from Genet International & FIRSTVET Veterinary Medicines Trading LLC The shares of the company have an ROE of 25 per cent and an ROCE of 32 per cent. Kiran Shroff / Wednesday, October 30, 2024 1 1058 Article rating: 3.5 The stock is up 34.21 per cent from its 52-week low of Rs 38.01 per share. Read more
Penny stock below Rs 50 jumps over 10 per cent as pharma company bags new order worth USD 17,700 from Al-Saqr Agro For Agricultural And Veterinary Entries Penny stock below Rs 50 jumps over 10 per cent as pharma company bags new order worth USD 17,700 from Al-Saqr Agro For Agricultural And Veterinary Entries The shares of the company have an ROE of 25 per cent and an ROCE of 32 per cent. Kiran Shroff / Thursday, September 19, 2024 0 541 Article rating: 3.9 The stock is up 30 per cent from its 52-week low of Rs 37.50 per share. Read more
230 per cent returns: This multibagger pharmaceutical company announced approval for a new drug from US FDA; do you own it? 230 per cent returns: This multibagger pharmaceutical company announced approval for a new drug from US FDA; do you own it? The company has delivered returns of 14.5 per cent over the past 3 years and returns of 230 per cent over the past 5 years. Siddharth Mane / Friday, July 14, 2023 0 14440 Article rating: 4.1 The company has a ROCE of 19.4 per cent and a ROE of 19.1 per cent. Read more
This innovative Pharma company launches Thiamine Hydrochloride Injection USP in the United States! This innovative Pharma company launches Thiamine Hydrochloride Injection USP in the United States! The company holds a leadership position in cardiovascular, anti-diabetic and respiratory segments and is the third-largest pharmaceutical company in the U.S. by prescriptions. Siddharth Mane / Monday, June 19, 2023 0 366 Article rating: 4.0 A global pharmaceutical company, has announced the launch of Thiamine Hydrochloride Injection USP, following the approval of its alliance partner Caplin Steriles Limited's ANDA by the U.S. FDA. Read more
Biggest IPO of 2023 gets listed; stock surges 31.86 per cent from issue price Biggest IPO of 2023 gets listed; stock surges 31.86 per cent from issue price IPO listed with a 20.37 per cent premium on the BSE! Kamal Mansuriya / Tuesday, May 9, 2023 0 1531 Article rating: 4.5 IPO listed with a 20.37 per cent premium on the BSE! Read more
Upper Circuit: This micro-cap pharma stock reported stellar Q3FY23 results! Upper Circuit: This micro-cap pharma stock reported stellar Q3FY23 results! In an aim to expand their product portfolio, the company is focusing on developing multiple manufacturing sites Bhavya Rathod / Monday, January 30, 2023 0 448 Article rating: 3.7 They initiated contract manufacturing from three new locations this quarter and with this, they are currently manufacturing at nine locations across India Read more
Only buyers: Shares of this pharmaceutical company are locked at 20 per cent upper circuit. Do you own it? Only buyers: Shares of this pharmaceutical company are locked at 20 per cent upper circuit. Do you own it? This stock is currently available at a PE multiple of 21.47 and an ROE of 9.68, all of which indicate good management effectiveness. Kiran Shroff / Tuesday, November 15, 2022 0 3173 Article rating: 4.3 This stock is currently available at a PE multiple of 21.47 and an ROE of 9.68, all of which indicate good management effectiveness. Read more
Shilpa Medicare skyrockets by 10.47 per cent on a weak market day! Shilpa Medicare skyrockets by 10.47 per cent on a weak market day! The board of the company also has recommended a dividend of Rs 1.10 per equity share for the financial year ended March 31, 2022.  Sayali Kotwal / Tuesday, May 24, 2022 0 515 Article rating: 5.0 The shares of Shilpa Medicare soared 10.47 per cent to Rs 453.25 on BSE after the company announced promising results for the quarter that ended on March 31, 2022. Read more